| Symbol: | PLXNB1 | 
	  
      
  	  | Description: | plexin B1 [Source:HGNC Symbol;Acc:9103] | 
      
  	  | Location: | Chr3:48445261-48471594[-] | 
	  
         
	   
       | CRmiRSNP:
	   
		
	   ~ Export ~ | 
      		Records:null
      		 
      			
      			
      				| Compound | CRmiRSNP | SNP_sig | Model | Molecule | Mol_sig | Type |  
      			Model : M1-Allele, M2-Recessive, M3-Additive, M4-DominantTotal:0 Current:1 
      			[First] [Prev] [Next] [Last]
 | 
	  
	  
	  
       | Compound:
	    
		
	    ~ Export ~ | 
      		Records:179			
      		 
      			
      				| Gene | Compound | Gen_sig | Exp_pattern |  
				    | PLXNB1 | NSC 103704 | 0.011 | Up |  
				    | PLXNB1 | NSC 106723 | 0.044 | Down |  
				    | PLXNB1 | AT 116, benzylamine salt | 0.009 | Up |  
				    | PLXNB1 | Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- | 0.01 | Up |  
				    | PLXNB1 | NSC 168197 | 0.027 | Down |  
				    | PLXNB1 | 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- | 0.008 | Down |  
				    | PLXNB1 | 9-METHOXYCAMPTOTHECIN | 0.011 | Up |  
				    | PLXNB1 | 1H-Pyrazole-1-ethanol, 4,4'-azoxybis(3,5-dimethyl- | 0.04 | Down |  
				    | PLXNB1 | Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- | 0.001 | Down |  
				    | PLXNB1 | NSC 23416 | 0.037 | Down |  
				    | PLXNB1 | Buclizine Hydrochloride | 0.041 | Down |  
				    | PLXNB1 | Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester | 0.009 | Down |  
				    | PLXNB1 | 3-Phenacyliden-5-brom-2-indolinon | 0.014 | Down |  
				    | PLXNB1 | NSC 295642 | 0.017 | Down |  
				    | PLXNB1 | NSC 311727 | 0.024 | Down |  
			 Expression pattern: Sensitivity / Resistance 
      			Total:12 Current:1 
      			[First] [Prev] Next Last  
      		 | 
	   
	  
       | SNP:
	   
		
	    ~ Export ~ | 
      		Records:13
      		 
      			Total:1 Current:1 
      			[First] [Prev] [Next] [Last] 
      		 | 
	  
	  
	  
       | miRNA:
	   
		
	    ~ Export ~ |  |